# Neeuro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neeuro

- Industry: Healthcare IT
- Headquarters: Singapore, Singapore
- Website: www.neeuro.com
- Total disclosed funding: $1.8M
- Latest round: Series A (Nov 11, 2019)
- Investors on record: 1

## About

Based in Singapore, and founded in 2013 by CEO Alvin Chan, Eddie Chau, and Kelly Choo, Neeuro Pte. Ltd., a.k.a. Neeuro is a health technology company that provides an artificial intelligence (AI) driven platform that empowers health care professionals, researchers, and third-party developers to analyze the brain signals of individuals as well as to measure their mental states.

The company provides NeeuroOS, a scalable platform that allows health care professionals, and researchers to interpret cognitive mental states through electrocardiogram (ECG) signals to drive interferences for brain health challenges in real-time. Neeuro also provides SenzeBand, a device used to capture brainwaves (ECG) to interpret multiple mental states, such as fatigue, stress, mental workload, relaxation, attention, and more. In addition, the solutions offered by Neeuro include brain fitness, digital therapeutics, and stress management for children, seniors, and professionals.

## Funding rounds

- Series A, Nov 11, 2019, $1.8M — TNF Ventures

## Investors

- TNF Ventures (https://capitalatlas.ai/funds/tnf-ventures) — Series A